What smart money is saying about Bicara Therapeutics
BCAX
No fund has written a full thesis on Bicara Therapeutics in our archive, but 1 fund letter reports a position in it, most recently Clearbridge Small Cap Strategy in September 2025.
Get an email when a fund buys, sells or pitches it
1
Reported positions
1
Bought
0
Sold
1
Letter
Position history
Every position in Bicara Therapeutics on record in the archive was reported in Q3 2025, across 1 fund letter, with 1 buy (opened or added).
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q3 2025 | 1 | 1 | 0 | 0 |
Bought and Sold count moves: the same sentence published by several funds of one house in a quarter counts once.
Fund activity · 1 position · 1 move
- New positionClearbridge Small Cap StrategySeptember 2025
“In addition to the transactions listed above, we initiated new positions in CG Oncology, Celcuity and Bicara Therapeutics in the health care sector, Freshpet in the consumer staples sector and Piedmont Realty Trust in the real estate sector.”
Bicara Therapeutics
Read the letters behind these Bicara Therapeutics positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves, and to Warren AI, which reads all of them for you.
View plans→Share this ledger